Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Adaptation of avian influenza virus to a swine host.

Bourret V, Lyall J, Frost SDW, Teillaud A, Smith CA, Leclaire S, Fu J, Gandon S, Guérin JL, Tiley LS.

Virus Evol. 2017 Mar 18;3(1):vex007. doi: 10.1093/ve/vex007. eCollection 2017 Jan.

2.

The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes.

Turrell L, Lyall JW, Tiley LS, Fodor E, Vreede FT.

Nat Commun. 2013;4:1591. doi: 10.1038/ncomms2589.

3.

The cytoplasmic location of chicken mx is not the determining factor for its lack of antiviral activity.

Benfield CT, Lyall JW, Tiley LS.

PLoS One. 2010 Aug 16;5(8):e12151. doi: 10.1371/journal.pone.0012151.

4.

An ex vivo swine tracheal organ culture for the study of influenza infection.

Nunes SF, Murcia PR, Tiley LS, Brown IH, Tucker AW, Maskell DJ, Wood JL.

Influenza Other Respir Viruses. 2010 Jan;4(1):7-15. doi: 10.1111/j.1750-2659.2009.00119.x.

5.

Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity.

Biswas S, Tiley LS, Zimmermann H, Birkmann A, Field HJ.

Antiviral Res. 2008 Oct;80(1):81-5. doi: 10.1016/j.antiviral.2008.04.005. Epub 2008 May 16.

PMID:
18539344
6.

Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays.

Benfield CT, Lyall JW, Kochs G, Tiley LS.

J Virol. 2008 Aug;82(15):7533-9. doi: 10.1128/JVI.00185-08. Epub 2008 May 28.

7.

A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target.

Biswas S, Kleymann G, Swift M, Tiley LS, Lyall J, Aguirre-Hernández J, Field HJ.

J Antimicrob Chemother. 2008 May;61(5):1044-7. doi: 10.1093/jac/dkn057. Epub 2008 Feb 25.

PMID:
18299638
8.

Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.

Hussein IT, Miguel RN, Tiley LS, Field HJ.

Arch Virol. 2008;153(3):495-505. doi: 10.1007/s00705-007-0021-6. Epub 2008 Jan 15.

PMID:
18196203
9.

Temperature sensitive influenza A virus genome replication results from low thermal stability of polymerase-cRNA complexes.

Dalton RM, Mullin AE, Amorim MJ, Medcalf E, Tiley LS, Digard P.

Virol J. 2006 Aug 25;3:58.

10.

Developments in transgenic technology: applications for medicine.

Hunter CV, Tiley LS, Sang HM.

Trends Mol Med. 2005 Jun;11(6):293-8. Review.

PMID:
15949771
11.

Restricted species tropism of maedi-visna virus strain EV-1 is not due to limited receptor distribution.

Lyall JW, Solanky N, Tiley LS.

J Gen Virol. 2000 Dec;81(Pt 12):2919-27.

PMID:
11086123
12.
13.

Sequence requirements for Rev multimerization in vivo.

Madore SJ, Tiley LS, Malim MH, Cullen BR.

Virology. 1994 Jul;202(1):186-94.

PMID:
7516596
15.

The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.

Tiley LS, Madore SJ, Malim MH, Cullen BR.

Genes Dev. 1992 Nov;6(11):2077-87.

16.
17.

Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.

Tiley LS, Malim MH, Tewary HK, Stockley PG, Cullen BR.

Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):758-62. Erratum in: Proc Natl Acad Sci U S A 1992 Mar 1;89(5):1997.

18.

Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.

Malim MH, McCarn DF, Tiley LS, Cullen BR.

J Virol. 1991 Aug;65(8):4248-54.

19.

Effect of RNA secondary structure on polyadenylation site selection.

Brown PH, Tiley LS, Cullen BR.

Genes Dev. 1991 Jul;5(7):1277-84.

20.
22.
23.

Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?

Tiley LS, Brown PH, Cullen BR.

Virology. 1990 Oct;178(2):560-7.

PMID:
2219707
24.

Visna virus encodes a post-transcriptional regulator of viral structural gene expression.

Tiley LS, Brown PH, Le SY, Maizel JV, Clements JE, Cullen BR.

Proc Natl Acad Sci U S A. 1990 Oct;87(19):7497-501. Erratum in: Proc Natl Acad Sci U S A 1990 Dec;87(23):9508.

25.

HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.

Malim MH, Tiley LS, McCarn DF, Rusche JR, Hauber J, Cullen BR.

Cell. 1990 Feb 23;60(4):675-83.

PMID:
2406030

Supplemental Content

Loading ...
Support Center